Mutations in the Primary Sigma Factor σ A and Termination Factor Rho That Reduce Susceptibility to Cell Wall Antibiotics

Abstract

ABSTRACT Combinations of glycopeptides and β-lactams exert synergistic antibacterial activity, but the evolutionary mechanisms driving resistance to both antibiotics remain largely unexplored. By repeated subculturing with increasing vancomycin (VAN) and cefuroxime (CEF) concentrations, we isolated an evolved strain of the model bacterium Bacillus subtilis with reduced susceptibility to both antibiotics. Whole-genome sequencing revealed point mutations in genes encoding the major σ factor of RNA polymerase ( sigA ), a cell shape-determining protein ( mreB ), and the ρ termination factor ( rho ). Genetic-reconstruction experiments demonstrated that the G-to-C substitution at position 336 encoded by sigA ( sigA G336C ), in the domain that recognizes the −35 promoter region, is sufficient to reduce susceptibility to VAN and works cooperatively with the rho G56C substitution to increase CEF resistance. Transcriptome analyses revealed that the sigA G336C substitution has wide-ranging effects, including elevated expression of the general stress σ factor (σ B ) regulon, which is required for CEF resistance, and decreased expression of the glpTQ genes, which leads to fosfomycin (FOS) resistance. Our findings suggest that mutations in the core transcriptional machinery may facilitate the evolution of resistance to multiple cell wall antibiotics.